Epstein-Barr virus sustains tumor killers

Nature Medicine

Volumn 14, Issue 11, 2008, Pages 1148-1150

  O'Reilly, Richard J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CHIMERIC ANTIGEN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

B LYMPHOCYTE; CANCER IMMUNOTHERAPY; CELL ACTIVATION; EPSTEIN BARR VIRUS; IMMUNE RESPONSE; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; TUMOR;

ANIMALS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; NEOPLASMS;

HUMAN HERPESVIRUS 4;

EID: 55549091096     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm1108-1148     Document Type: Short Survey

References (13)

1. Pule, M.A. et al. Nat. Med. 14, 1264-1270.
2. Benninger-Doring, G. et al. Virology 264, 289-297 (1999).
3. Heslop, H.E. et al. Nat. Med. 2, 551-555 (1996).
4. Sadelain, M., Riviere, I. & Brentjens, R. Nat. Rev. Cancer 3, 35-45 (2003).
5. Rossig, C., Bollard, C.M., Nuchtern, J.G., Rooney, C.M. & Brenner, M.K. Blood 99, 2009-2016 (2002).
6. Park, J.R. et al. Mol. Ther. 15, 825-833 (2007).
7. Kramer, K. et al. Clin. Cancer Res. 4, 2135-2139 (1998).
8. Frost, J.D. et al. Cancer 80, 317-333 (1997).
9. Cheung, N.K. et al. J. Clin. Oncol. 16, 3053-3060 (1998).
10. Berger, C. et al. J. Clin. Invest. 118, 294-305 (2008).
11. Krause, A. et al. J. Exp. Med. 188, 619-626 (1998).
12. Maher, J., Brentjens, R.J., Gunset, G., Riviere, I. & Sadelain, M. Nat. Biotechnol. 20, 70-75 (2002).
13. Stephan, M.T. et al. Nat. Med. 13, 1440-1449 (2007).